Paper186397
The co-carcinogenic activity of 4-nitropyridine-1-oxide (4-NPO) and prevention of transformation by type-specific anti-viral antibodies.
Price PJ and 4 others. In Vitro, 1976. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The co-carcinogenic activity of 4-nitropyridine-1-oxide (4-NPO) and prevention of transformation by type-specific anti-viral antibodies. Papers, record 186397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/186397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The co-carcinogenic activity of 4-nitropyridine-1-oxide (4-NPO) and prevention of transformation by type-specific anti-viral antibodies.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Cyclic N-Oxides | Major topic |
| Pyridines | Major topic |
| Rauscher Virus | Major topic |
| 4-Nitroquinoline-1-oxide | |
| Animals | |
| Cell Line | |
| Cocarcinogenesis | |
| Gammaretrovirus | |
| Rats | |
| Species Specificity |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 4343229 | Sensitivity of repair-deficient mutants and similar mutants to 4-nitroquinoline 1-oxide, 4-nitropyridine 1-oxide, and their derivatives. | Cancer Res | 1972 | https://conductscience.org/library/papers/4343229 | PubMed |
| 3 | 4883335 | On the association between lysogeny and carcinogenicity in nitroquinolines and related compounds. | Experientia | 1968 | https://conductscience.org/library/papers/4883335 | PubMed |
| 4 | 5062857 | Assay of C-type virus infectivity by measurement of RNA-dependent DNA polymerase activity. | Virology | 1972 | https://conductscience.org/library/papers/5062857 | PubMed |
| 6 | 4926995 | DNA repair synthesis in mammalian cells exposed to a series of oncogenic and non-oncogenic derivatives of 4-nitroquinoline 1-oxide. | Nature | 1971 | https://conductscience.org/library/papers/4926995 | PubMed |
| 7 | 5573958 | Hycanthone: a frameshift mutagen. | Science | 1971 | https://conductscience.org/library/papers/5573958 | PubMed |
| 8 | 265524 | Chemical transformation of rat cells infected with xenotropic type-C RNA virus and its suppression by virus-specific antiserum. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/265524 | PubMed |
| 9 | 4134493 | 5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4134493 | PubMed |
| 10 | 1061110 | Prevention of viral-chemical co-carcinogenesis in vitro by type-specific anti-viral antibody. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1061110 | PubMed |
| 11 | 50281 | I. In vitrol transformation of rat embryo cells: correlations with the known tumorigenic activities of chemicals in rodents. | In Vitro | 1975 | https://conductscience.org/library/papers/50281 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/186397
GET https://conductscience.org/api/papers/v1/186397/authors